Tremfya and Azelastine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tremfya (guselkumab) and Azelastine (azelastine hydrochloride). Common drug interactions include influenza among females.

The phase IV clinical study analyzes what interactions people have when they take Tremfya and Azelastine. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Tremfya?

Tremfya has active ingredients of guselkumab. eHealthMe is studying from 22,557 Tremfya users. Check the latest studies of Tremfya.

What is Azelastine?

Azelastine has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 17,400 Azelastine users. Check the latest studies of Azelastine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

12 people who take Tremfya and Azelastine together, and have interactions are studied.

Tremfya and Azelastine drug interactions.

What are the common drug interactions of Tremfya and Azelastine, by gender? *:

female:

Influenza
Respiratory tract infection
Fatigue (feeling of tiredness)
Injection site reaction
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Pneumonia
Productive cough
Rash
Vomiting

male:

n/a

What are the common drug interactions of Tremfya and Azelastine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Urticaria (rash of round, red welts on the skin that itch intensely)

30-39:

n/a

40-49:

Hypertension (high blood pressure)

50-59:

Influenza
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Injection site reaction
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Pneumonia
Productive cough
Vomiting
Respiratory tract infection

60+:

Rash

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 5 people, 41.67%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 5 people, 41.67%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 16.67%
Dry Mouth: 1 person, 8.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tremfya and Azelastine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously